Multiple myeloma Clinical Trials in New York, NY

As of June 2026, 52 paid clinical trials are recruiting for Multiple myeloma in New York, New York. Recruiting Multiple myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Related specialties in New York

Oncology· 1,447 Blood cancer· 292

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

52 clinical trials for Multiple myeloma

·Clear filters·↓ Download CSV

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

5 locations incl. Birmingham

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT05372354·Phase 1, Phase 2·Recruiting

Apply to this trial

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for Multiple Myeloma

Drug: Teclistamab

42 locations incl. Phoenix

Sponsor: European Myeloma Network B.V.

Sex: All·Age: 18+

Code: NCT05243797·Phase 3·Recruiting

Apply to this trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for Multiple Myeloma

Drug: Linvoseltamab

13 locations incl. La Jolla

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT05137054·Phase 1·Recruiting

Apply to this trial

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

for Multiple Myeloma

28 locations incl. Phoenix

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05201781·Phase 4·Recruiting

Apply to this trial

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for Leukemia, Myeloid, Acute

33 locations incl. Newport Beach

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 12+

Code: NCT04988555·Phase 1, Phase 2·Recruiting

Apply to this trial

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

for Multiple Myeloma

3 locations incl. Atlanta

Sponsor: Heidelberg Pharma AG

Sex: All·Age: 18+

Code: NCT04879043·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

for Multiple Myeloma

Drug: Daratumumab

11 locations incl. Clovis

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT05020236·Phase 3·Recruiting

Apply to this trial

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

for Non-Hodgkin Lymphoma

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05093335·EARLY_Phase 1·Recruiting

Apply to this trial

Study of CAR-T Therapy in Older Patients

for Lymphoma

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 60+

Code: NCT04300998·Recruiting

Apply to this trial

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

for Multiple Myeloma

Drug: Linvoseltamab

14 locations incl. Miami

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT03761108·Phase 1, Phase 2·Recruiting

Apply to this trial

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for Lymphoma, Non-Hodgkin

174 locations incl. Birmingham

Sponsor: American Society of Clinical Oncology

Sex: All·Age: 12+

Code: NCT02693535·Phase 2·Recruiting

Apply to this trial

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

for Lymphoma

6 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT00582621·Recruiting

Apply to this trial